Literature DB >> 18680775

Ceramide elevates 12-hydroxyeicosatetraenoic acid levels and upregulates 12-lipoxygenase in rat primary hippocampal cell cultures containing predominantly astrocytes.

Vidudala V T S Prasad1, Kassem Nithipatikom, David R Harder.   

Abstract

We report, exogenous addition of ceramide significantly increases 12-hydroxyeicosatetraenoic acid [12-(S)-HETE] levels, in a dose-dependent manner. 12-(S)-HETE levels, in 20, 30 and 40microM ceramide exposed rat primary hippocampal cell cultures containing predominantly astrocytes and few neurons and other glial cells (the cultured hippocampal cells were predominantly astrocytes amounting to over 99% of total cells with few neurons and other glial cells) amounted to 207, 260 and 408% of the controls, respectively. However, dihydroceramide, an inactive analog of ceramide did not alter the levels of 12-(S)-HETE. Ceramide also increased the mRNA and protein expression, and activity of 12-lipoxygease (12-LOX) needed for the synthesis of 12(S)-HETE. These results indicate a possible link between ceramide and 12-LOX pathway. However, ceramide did not alter expression of 5-lipoxygenase (5-LOX), another member of the lipoxygenase family. However, ceramide upregulated expression of cytosolic phospholipase-A(2) (cPLA(2)) and cyclooxygenase-2 (COX-2). Further, ceramide caused a significant increase in the levels of reactive oxygen species (ROS). Ceramide-mediated generation of ROS was inhibited by baicalien but not by indomethacin. In addition, ceramide treated cells exhibited increased mRNA expression of DNA damage induced transcript3 (Ddit3). This report which demonstrate induction of pro-carcinogenic 12-LOX pathway by an anticancer ceramide, may be relevant to cancer biologists studying drug resistant tumors and devising potent anticancer therapeutic strategies to treat drug resistant tumors. These results indicate possibility of 12-LOX involvement in ceramide-mediated generation of ROS and cellular oxidative stress. Induction of 12-LOX pathway by ceramide may have implications in understanding pathophysiology of neurodegenerative diseases involving ROS generation and inflammation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680775     DOI: 10.1016/j.neuint.2008.07.002

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  14 in total

1.  Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies.

Authors:  Irina G Obrosova; Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Jerry L Nadler; Robert E Schmidt
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies.

Authors:  Roman Stavniichuk; Viktor R Drel; Hanna Shevalye; Igor Vareniuk; Martin J Stevens; Jerry L Nadler; Irina G Obrosova
Journal:  Free Radic Biol Med       Date:  2010-06-22       Impact factor: 7.376

3.  Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.

Authors:  Vidudala V T S Prasad; Padma Kolli; Divya Moganti
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

4.  Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression.

Authors:  Joseph C Mazzei; Hui Zhou; Bradley P Brayfield; Raquel Hontecillas; Josep Bassaganya-Riera; Eva M Schmelz
Journal:  J Nutr Biochem       Date:  2011-02-04       Impact factor: 6.048

Review 5.  Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise.

Authors:  Fei Yin
Journal:  FEBS J       Date:  2022-01-07       Impact factor: 5.622

Review 6.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

Review 7.  Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.

Authors:  Grace Y Sun; Dennis Y Chuang; Yijia Zong; Jinghua Jiang; James C M Lee; Zezong Gu; Agnes Simonyi
Journal:  Mol Neurobiol       Date:  2014-02-27       Impact factor: 5.590

8.  Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability.

Authors:  V P Chou; T R Holman; A B Manning-Bog
Journal:  Neuroscience       Date:  2012-10-16       Impact factor: 3.590

9.  Non-synonymous polymorphism (Gln261Arg) of 12-lipoxygenase in colorectal and thyroid cancers.

Authors:  Vidudala V T S Prasad; Kolli Padma
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

Review 10.  Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation.

Authors:  Maja Jazvinšćak Jembrek; Patrick R Hof; Goran Šimić
Journal:  Oxid Med Cell Longev       Date:  2015-05-24       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.